Cormark Raises Vitalhub (TSE:VHI) Price Target to C$10.50

Vitalhub (TSE:VHI) had its target price hoisted by stock analysts at Cormark from C$9.50 to C$10.50 in a note issued to investors on Wednesday, BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Cormark’s price objective would indicate a potential upside of 19.59% from the stock’s current price. Cormark also issued estimates for Vitalhub’s FY2025 earnings at $0.22 EPS.

Vitalhub Trading Up 2.1 %

Shares of TSE:VHI opened at C$8.78 on Wednesday. The stock has a market capitalization of C$446.46 million, a P/E ratio of 79.82, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. The stock’s 50-day moving average price is C$8.31 and its 200-day moving average price is C$7.31. Vitalhub has a 12-month low of C$2.75 and a 12-month high of C$9.09.

Vitalhub (TSE:VHI) last posted its quarterly earnings results on Thursday, August 8th. The company reported C($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.06 by C($0.07). The company had revenue of C$16.24 million for the quarter, compared to the consensus estimate of C$15.39 million. Vitalhub had a return on equity of 4.73% and a net margin of 8.14%. As a group, research analysts predict that Vitalhub will post 0.2301144 EPS for the current year.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.